Antioxidant effects of simvastatin in patients with coronary heart disease and dyslipidemia

Antioxidant effects of simvastatin in patients with coronary heart disease and dyslipidemia

Aim. To investigate the effects of simvastatin therapy on antioxidant enzyme activity and the correction of disturbed antioxidant status in patients with coronary heart disease (CHD) – post-infarction cardiosclerosis (PICS) – in combination with dyslipidemia (DLP). Material and methods. The study in...

Full description

Bibliographic Details
Main Authors:	N. E. Artamoshina, K. Yu. Bondar, O. L. Belaya, L. M. Bayder, Z. V. Kuropteva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2012-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	симвастатин ишемическая болезнь сердца антиоксидантные ферменты церулоплазмин трансферрин
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1955

Similar Items

Antioxidant status and lipid peroxidation in stable coronary heart disease patients with dyslipidemia
by: O. L. Belaya, et al.
Published: (2006-10-01)

The effect of use simvastatin at treatment of ischemic heart disease patients of senile age
by: A. L. Pirogov, et al.
Published: (2007-10-01)

Use the product mares milk in rehabilitation of patients with ischemic heart disease
by: L. T. Gilmutdinova, et al.
Published: (2010-06-01)

Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
by: V. V. Novitsky, et al.
Published: (2008-09-01)

Change in the fatty acids spectrum of erythrocyte in patients with chronic form of coronary heart disease in treatment by Simvastatin
by: V. V. Novitsky, et al.
Published: (2012-02-01)

Dose-dependent effect of statins on the change in the content of individual fatty acids of blood serum and their complexes of men and women with secondary prevention of chronic coronary heart disease
by: M. Yu. Kotlovsky, et al.
Published: (2018-03-01)

Clinical effects of statins: focusing on simvastatin
by: D. M. Aronov, et al.
Published: (2009-04-01)

ASSOCIATION OF POLYMORPHISM RS3846663 IN HMG-CoA REDUCTASE GENE WITH THE EFFECTIVENESS OF STATIN THERAPY IN PATIENTS WITH CORONARY HEART DISEASE
by: Aleksey Vladimirovich Osedko, et al.
Published: (2019-05-01)

Dyslipidemia correction with atorvastatin in patients with coronary heart disease and arterial hypertension
by: N. B. Amirov, et al.
Published: (1970-01-01)

The Modulating Effect of Perfluorane on the Ratio of Pro- to Antioxidative Systems in Different Organs
by: A. G. Zhukova, et al.
Published: (2006-02-01)

Investigation of the antioxidant status and the number of double-stranded DNA breaks in models of brain tumor lesion by metastases of non-small cell lung cancer in vivo
by: E. V. Zaikina, et al.
Published: (2022-12-01)

Hyperhomocysteinemia and lipid peroxidation in stable coronary heart disease
by: O. L. Belaya, et al.
Published: (2007-02-01)

The specific features of the diagnosis and treatment of coronary heart disease in rheumatoid arthritis (Results of the authors’ studies)
by: Natalya Anatolyevna Khramtsova, et al.
Published: (2012-06-01)

Relationship between coronary artery calcification and osteopenic syndrome in men with coronary heart disease
by: T. A. Raskina, et al.
Published: (2016-06-01)

Impact of polarized polychromatic incoherent light upon bioradical parameters of rat tissues and blood serum
by: Н. В. Хмиль, et al.
Published: (2015-04-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

Dysregulatory Changes in the Lymphocytic Antiradical Defense System in Severe Concomitant Brain Injury
by: T. F. Sokolova, et al.
Published: (2007-12-01)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

CEREBROVASCULAR PATHOLOGY IN PATIENTS WITH CORONARY HEART DISEASE (NEROIMAGING RESULTS)
by: Irina Danilovna Syrova, et al.
Published: (2023-09-01)

OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01)

Epidemiology of acute coronary heart disease in the Russian Federation: experience and perspectives
by: S. S. Yakushin, et al.
Published: (2009-08-01)

Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
by: M. G. Bubnova
Published: (2009-08-01)

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease
by: O. A. Vartanova, et al.
Published: (2008-06-01)

Respiratory function in patients with coronary heart disease in combination with chronic obstructive pulmonary disease
by: А. С. Клинкова, et al.
Published: (2015-10-01)

THE EFFECTIVENESS OF MEDICAL REHABILITATION IN CORONARY HEART DISEASE AS A PART OF THE SPA RESORT TREATMENT
by: A. S. Ivashchenko, et al.
Published: (2017-06-01)

THE STATE OF THE CORONARY BED IN CORONARY HEART DISEASE IN PATIENTS WITH HYPOTHYROIDISM
by: Muneer Abdul Rahman, et al.
Published: (2023-12-01)

Structural and functional base of coronary heart disease typology
by: A. S. Dimov, et al.
Published: (1970-01-01)

Cardiovascular risk stratification in elderly men with coronary heart disease
by: E. G. Volkova, et al.
Published: (2008-12-01)

State of microcircuiation in cardiac chamber walls in elderly patients with aortic stenosis combined with coronary heart disease
by: A. M. Karaskov, et al.
Published: (2018-06-01)

EVALUATION OF MYOCARDIAL REVASCULARIZATION IN STABLE CORONARY HEART DISEASE PATIENTS AND FACTORS ASSOCIATED WITH INVASIVE STRATEGY CHOICE
by: A. S. Korotin, et al.
Published: (2017-08-01)

Prevalence of ischemic heart disease among males with tuberculosis
by: V A Koshechkin, et al.
Published: (2011-09-01)

Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation
by: F. T. Ageev, et al.
Published: (2011-06-01)

Helicobacteriosis and coronary heart disease: synthropic pathogenesis
by: O. N. Pavlov
Published: (2009-06-01)

Antiplatelet drug resistance in patients with coronary heart disease
by: V. A. Sulimov, et al.
Published: (2012-12-01)

Effectiveness of lipid-lowering therapy in outpatients with coronary artery disease living in a large industrial center of Eastern Siberia
by: N. G. Gogolashvili, et al.
Published: (2022-01-01)

CARDIO-ANKLE VASCULAR INDEX IN PATIENTS WITH CORONARY HEART DISEASE: ROLE OF PERIPHERAL ATHEROSCLEROSIS
by: A. N. Sumin, et al.
Published: (2013-10-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

Coronary heart disease development in heterozygotic form of familial hypercholesterolemia
by: P. P. Malyshev, et al.
Published: (2006-10-01)

Constitutional and genetic model of high coronary heart disease risk
by: O. I. Boeva, et al.
Published: (2007-08-01)

CONTEMPORARY APPROACHES TO ANTIPLATELET THERAPY IN CORONARY HEART DISEASE TREATMENT
by: S. T. Matskeplishvili, et al.
Published: (2014-08-01)